Scilex Holding (SCLX) Preferred Dividend Payments (2025)
Scilex Holding (SCLX) posted quarterly Preferred Dividend Payments of -$47000.0 for Q4 2025, up 99.89% quarter-over-quarter from -$43.8 million in Q2 2025.
Scilex Holding (SCLX) Preferred Dividend Payments (2025) Analysis & Trends
Scilex Holding's Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at -$47000.0 for Q4 2025.
- In Q4 2025, Preferred Dividend Payments changed N/A year-over-year to -$47000.0; the TTM figure through Dec 2025 stood at -$43.8 million (changed N/A YoY), while the FY2025 annual figure was -$43.8 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q4 2025 stood at -$47000.0, up from -$43.8 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was -$47000.0 in Q4 2025, with the low at -$43.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | - |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | - |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | - |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Scilex Holding | 39.35 Mn | -73.44 Mn | 3.97 Mn | -1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -47,000.00 |
| Jun 30, 2025 | -43.75 Mn |